Company intelligence / Profile preview

Nox Medical

Ownership: Private
Development stage: Commercial

Overview

Nox Medical’s diagnostic devices and AI-powered platforms are commercially available worldwide. Their technologies are validated across diverse populations, used in both home and clinical settings, and have been adopted by major healthcare providers to streamline the diagnosis of a wide range of sleep disorders. The company’s AI algorithms for sleep staging, apnea-hypopnea index calculation, oxygen desaturation detection, respiratory event scoring, and periodic limb movement analysis have been validated in multiple research studies.

Therapeutic areas: PulmonologyPsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (diagnostic devices)Artificial intelligence software platform
Industry: Physiological Monitoring

Partnerships

Strategic investment from Vestar Capital Partners

Beyond the preview

Go deeper on Nox Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nox Medical.

Explore the full profile